How Safe in Bharat Biotech's Covaxin for Vaccinating Children?

In big news in India’s vaccination drive, the Subject Expert Committee (SEC) recommended to the Drug Controller General of India (DCGI) to grant emergency use authorisation for Bharat Biotech’s Covaxin for children as young as two years.

On 12 October, the expert panel in a statement said that “after detailed deliberation, the committee recommended for grant of market authorisation of the vaccine for the age group of 2 to 17 years for restricted use in an emergency.”

This announcement makes Covaxin the second vaccine after Zydus Cadila’s ZyCoV-D DNA based vaccine, to be approved for vaccinating those under the age of 18, and the first vaccine in the world to be approved for children below the age of 12.

Though DCGI has not given the formal nod yet, the lack of publicly available data regarding the clinical trials and the fact that Covaxin has still not been approved by the World Health Organisation has raised some concerns with health experts on how effective the vaccine will be on children.

What also does not help Bharat Biotech’s case is its previous lack of transparency about the conduct of Covaxin clinical trials in adults and how it reported adverse side effects.

And this brings up the pertinent questions on every parents mind-how safe is Covaxin for children? How many doses should be administered? And do children already affected with COVID-19 need the vaccine?

Host and Producer: Himmat Shaligram

Guest: Dr Gagandeep Kang, a renowned virologist with CMC Vellore and a member of the National Technical Advisory Group on Immunisation (NTAGI)

Editor: Shelly Walia

Music: Big Bang Fuzz

Listen to The Big Story podcast on:

Apple: https://apple.co/2AYdLIl

Saavn: http://bit.ly/2oix78C

Google Podcasts: http://bit.ly/2ntMV7S

Spotify: https://spoti.fi/2IyLAUQ

Deezer: http://bit.ly/2Vrf5Ng

Castbox: http://bit.ly/2VqZ9ur

To help us answer these questions, for today’s episode we spoke to Dr Gagandeep Kang, a renowned virologist with CMC Vellore and a member of the COVID-19 World Group the National Technical Advisory Group on Immunisation.

Learn more about your ad choices. Visit megaphone.fm/adchoices